AbbVie (ABBV) Income from Non-Controlling Interests (2020 - 2026)

AbbVie (ABBV) has reported Income from Non-Controlling Interests for 7 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Income from Non-Controlling Interests changed 0.0% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $6.0 million, a 25.0% decrease from a year earlier, with the FY2025 full-year figure at $7.0 million, down 12.5% from the prior year.
• Income from Non-Controlling Interests was $3.0 million for Q2 2026 at AbbVie, up from $2.0 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $4.0 million in Q2 2022 and troughed at -$1.0 million in Q4 2022.
• A 5-year average of $2.2 million and a median of $3.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
• Across the five-year window, Income from Non-Controlling Interests sank 200.0% in 2022 and surged 300.0% in 2023, its largest moves.
• Over 5 years, Income from Non-Controlling Interests stood at -$1.0 million in 2022, then surged by 300.0% to $2.0 million in 2023, then slumped by 150.0% to -$1.0 million in 2024, then changed by 0.0% to -$1.0 million in 2025, then jumped by 400.0% to $3.0 million in 2026.
• The last three Income from Non-Controlling Interests figures came in at $3.0 million (Q2 2026), $2.0 million (Q1 2026), and -$1.0 million (Q4 2025), per Business Quant data.